Germany
· Delayed Price · Currency is EUR Dermapharm Holding SE Company Description
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
The company operates through three segments: Branded Pharmaceuticals, Other Healthcare Products, and Parallel Import Business.
It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals.
The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology.
In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand.
It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, and Herpotherm brands.
The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-AG.
| Country | Germany |
| Founded | 1991 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 3,610 |
| CEO | Hans-Georg Feldmeier |
Contact Details
Address: Lil-Dagover-Ring 7 Grünwald, 82031 Germany | |
| Phone | 49 89 6 41 86 0 |
| Website | ir.dermapharm.de |
Stock Details
| Ticker Symbol | DMP |
| Exchange | Deutsche Börse Xetra |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A2GS5D8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Hans-Georg Feldmeier | Chief Executive Officer and Chairman of the Management Board |
| Christof Dreibholz | Chief Financial Officer, Chief Compliance Officer and Member of Management Board |
| Dr. Andreas Eberhorn | Chief Marketing Officer and Member of Management Board |
| Britta Hamberger | Head of Investor Relations and Corporate Communications |